Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 47.55% is 347% above its 5-year average of -19.24%, near the high end of its 5-year range (-43.43%–47.55%).
As of the fiscal period ended Tuesday, June 30, 2026. 518.50% above its 12-month average of 7.69%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 47.55%.
RETURN ON INVESTED CAPITAL (ROIC)
47.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
7.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-23.52%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-19.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-16.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+518.50%
CURRENT VS 3Y AVG
+302.20%
CURRENT VS 5Y AVG
+347.21%
CURRENT VS 10Y AVG
+381.02%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-27.33%
median of 444 covered companies
CURRENT VS SECTOR MEDIAN
+274.00%
vs the sector median at left
AnaptysBio, Inc.
Market Cap
$1.46B
Return on Invested Capital (ROIC)
47.55%
TTM Avg
7.69%
3Y Avg
-23.52%
5Y Avg
-19.24%
Market Cap
$1.45B
Return on Invested Capital (ROIC)
16.83%
TTM Avg
6.43%
3Y Avg
6.32%
5Y Avg
5.53%
Market Cap
$1.43B
Return on Invested Capital (ROIC)
-38.09%
TTM Avg
-38.09%
3Y Avg
-38.09%
5Y Avg
-38.09%
Market Cap
$1.51B
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.52B
Return on Invested Capital (ROIC)
-19.87%
TTM Avg
-24.87%
3Y Avg
-20.19%
5Y Avg
-15.68%
Market Cap
$1.52B
Return on Invested Capital (ROIC)
8.36%
TTM Avg
8.44%
3Y Avg
9.74%
5Y Avg
16.58%
Market Cap
$1.52B
Return on Invested Capital (ROIC)
20.41%
TTM Avg
-2.25%
3Y Avg
-13.09%
5Y Avg
-29.56%
Market Cap
$1.39B
Return on Invested Capital (ROIC)
-99.35%
TTM Avg
-175.72%
3Y Avg
-121.81%
5Y Avg
-100.94%
Market Cap
$1.57B
Return on Invested Capital (ROIC)
0.59%
TTM Avg
0.35%
3Y Avg
-0.10%
5Y Avg
-0.25%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AnaptysBio, Inc. (ANAB) | $1.46B | 47.55% | 7.69% | -23.52% | -19.24% |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | 16.83% | 6.43% | 6.32% | 5.53% |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.43B | -38.09% | -38.09% | -38.09% | -38.09% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.51B | N/A | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.52B | -19.87% | -24.87% | -20.19% | -15.68% |
| Innoviva, Inc. (INVA)vs › | $1.52B | 8.36% | 8.44% | 9.74% | 16.58% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 20.41% | -2.25% | -13.09% | -29.56% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.39B | -99.35% | -175.72% | -121.81% | -100.94% |
| Certara, Inc. (CERT)vs › | $1.57B | 0.59% | 0.35% | -0.10% | -0.25% |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.34B | -40.47% | -45.26% | -38.46% | -34.74% |
ROIC
47.6%
ROE
1849.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 47.55% |
| 2026-03-31 | 14.06% |
| 2025-12-31 | 14.61% |
| 2025-09-30 | -9.04% |
| 2025-06-30 | -28.74% |
| 2025-03-31 | -26.53% |
| 2024-12-31 | -26.22% |
| 2024-09-30 | -32.79% |
| 2024-06-30 | -41.97% |
| 2024-03-31 | -43.43% |
| 2023-12-31 | -39.62% |
| 2023-09-30 | -33.08% |
| 2023-06-30 | -29.48% |
| 2023-03-31 | -24.77% |
| 2022-12-31 | -19.71% |
| 2022-09-30 | -20.14% |
| 2022-06-30 | -16.69% |
| 2022-03-31 | -11.60% |
| 2021-12-31 | -9.06% |
| 2021-09-30 | 1.91% |
| 2021-06-30 | -2.44% |
| 2021-03-31 | -8.37% |
| 2020-12-31 | -6.02% |
| 2020-09-30 | -22.06% |
| 2020-06-30 | -23.29% |
| 2020-03-31 | -23.20% |
| 2019-12-31 | -26.42% |
| 2019-09-30 | -24.70% |
| 2019-06-30 | -19.39% |
| 2019-03-31 | -15.91% |
| 2018-12-31 | -13.49% |
| 2018-09-30 | -10.63% |
| 2018-06-30 | -15.64% |
| 2018-03-31 | -11.22% |
| 2017-12-31 | -8.93% |
| 2017-09-30 | -21.43% |
| 2017-06-30 | -13.60% |
| 2017-03-31 | -9.56% |
| 2016-12-31 | -5.36% |
| 2016-09-30 | -6.90% |
| 2016-06-30 | -6.04% |
| 2016-03-31 | -10.03% |
| 2015-12-31 | -6.79% |
| 2015-09-30 | 1.52% |
| 2015-06-30 | 39.86% |
| 2015-03-31 | 48.85% |
| 2014-12-31 | 36.38% |
